Description
GenJetInVitroDNATransfectionReagent(Ver.II)isupgradedversionofGenJetInVitroDNATransfectionReagent.Adoptinganewchemistry,moreDNAcondensinggroupswereliberatedinGenJet(Ver.II)(100%vs.80%inoldversion),leADIngto3~4foldsincreaseoftransfectionefficiencywithoutsacrificingcellviABIlity.GenJet(Ver.II)reagent,1.0ml,issufficientfor~667transfectionsin24wellplatesor~333transfectionsin6wellplates.
FeaturescomparedwitholdversionGenJetInVitroDNATrasnfectionReagent
-Cell-dependent3~4timeshigherefficiency
-Topchoiceforhard-to-transfectcells
-Efficiencyboostedinthepresenceofserumandantibioticsformostofcelltypes
-Exceptionalhighlevelsofrecombinantproteinproduction
StorageCondition
Storeat4°C.Ifstoredproperly,theproductisstablefor12monthsorlonger.
ComparisonsofTransfectionEfficiencyandCytotoxicityofGenJet(Ver.II)withOldVersionGenJetandOtherLeadingProducts
Comparisonoftransfectionefficiency(leftpanel)andtoxicity(rightpanel)GenJetVer.IIwitholdversionGenJetoncommonlyusedmammaliancells.phRL-CMVencodingRenillaLuciferasewasintroducedintocellswiththepresenceofserumandantibiotics.TheRenilliaLuciferaseactivitywasdeterminedwithRenillaLuciferaaseAssaySystem(Promega).Forcytotoxicity,MTTassaywasemployedtodeterminecellviabilitywithuntransfectedcontrolas100%.
AcomparisonoftransfectionefficiencyofGenJet(Ver.II)vs.Lipofectamine2000onprimaryrataorticsmoothmusclecells.PrimaryrataorticsmoothmusclecellswerepreparedandtransfectedwithanucleartargetedGFPCDNAbyGenJet(rightpanel)andLipofectamine2000(L2K,leftpanel)respectively.ThetransfectionefficiencywerecheckedunderaNikonEclipse2000fluorescencemicroscopy48hoursposttransfection
UpperPanel:TransfectionefficiencycomparisonofGenJetVer.IIwitholdversionGenJeton293Tcells.pEGFP-N3wastransfectedto293Tcellsat90%confluencywithpresenceofserumandantibiotics.GFPfluorescencewasdetectedwithNikonEclipse2000microscopy48hoursposttransfection
Lowerpanel:TransfectionefficiencycomparisonofGenJetVer.IIwitholdversionGenJetonHelacells.pEGFP-N3wastransfectedtoHelacellsat90%confluencywithpresenceofserumandantibiotics.GFPfluorescencewasdetectedwithNikonEclipse2000microscopy48hoursposttransfection
TechnicalInformation&Datasheet
-ACompleteTransfectionProtocol
-AShortProtocolforAdvancedUsers
-AProtocolforTransfectingSUSPension293andCHOCells
- AProtocolforLentivirusProduction
- AProtocolrAAVProduction
-TechnicalNote&TransfectionTips
RelatedProduct:GenJetInVitroDNATransfectionreagent
Torequestafreetrialsample,pleaseCreateAnAccountwithustoenteryourshippingaddressandemailusatorder@Signagen.com
SignaGen公司是一家专注于开发和生产基因转导工具的企业,服务于生物医学研究领域。借助我们独有的技术平台(美国专利商标局号码为 072308和61135606),SignaGen已经成功开发出三大类 DNA/siRNA转染试剂,经验证我们的产品比市场上主导产品效率更高,细胞毒性更低。更重要的是我们提供一个合理的价位。